A. Chabbou
Impact in
- Ophthalmology top 5%
- Ocular Diseases and Behçet’s Syndrome
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
-
- Tracheal and airway disorders 4
- Rheumatology 15
- Systemic Lupus Erythematosus Research 5
- Co-authors
- Mohamed‐Ridha Barbouche (2 shared papers)Koussay Dellagi (2 shared papers)Meriem Ben‐Ali (2 shared papers)A. Hamzaoui (7 shared papers)Kamel Hamzaoui (6 shared papers)Fayçal Hentati (2 shared papers)Kamel Hamzaoui (7 shared papers)A Kahán (2 shared papers)
- Journals
- Journal of Medical Microbiology (1 paper)Lara D. Veeken (1 paper)Diagnostic and Interventional Imaging (1 paper)Human Immunology (1 paper)Lung Cancer (1 paper)
- Partner nations
- TunisiaFranceSwitzerland
In The Last Decade
A. Chabbou
68 papers receiving 655 citations
Peers
Comparison fields: 5 of 76
- Ophthalmology 101
- Infectious Diseases 166
- Immunology 183
- Epidemiology 163
- Rheumatology 66
Countries citing papers authored by A. Chabbou
This map shows the geographic impact of A. Chabbou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Chabbou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Chabbou more than expected).
Fields of papers citing papers by A. Chabbou
This network shows the impact of papers produced by A. Chabbou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Chabbou. The network helps show where A. Chabbou may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Chabbou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 205 | |
| 2 | Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease. | 1994 | 67 |
| 3 | 2007 | 33 | |
| 4 | 1999 | 28 | |
| 5 | 2008 | 28 | |
| 6 | 1999 | 19 | |
| 7 | 1998 | 18 | |
| 8 | 1996 | 13 | |
| 9 | 2012 | 12 | |
| 10 | Combined C-reactive protein and Neutrophil to Lymphocyte ratio use predict survival innon-small-cell lung cancer. | 2017 | 11 |
| 11 | Impact of malnutrition in advanced non-small cell lung cancer. | 2018 | 11 |
| 12 | 2006 | 11 | |
| 13 | 2009 | 11 | |
| 14 | 2008 | 10 | |
| 15 | 2009 | 10 | |
| 16 | 2010 | 10 | |
| 17 | [Eosinophilic pleural effusion]. | 1989 | 10 |
| 18 | 2011 | 9 | |
| 19 | 1993 | 9 | |
| 20 | 1992 | 8 |
About A. Chabbou
A. Chabbou is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Surgery, Epidemiology and Infectious Diseases, having authored 81 papers that have together received 683 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (9 papers), Tuberculosis Research and Epidemiology (9 papers), Systemic Lupus Erythematosus Research (5 papers), Vascular Anomalies and Treatments (5 papers), Tracheal and airway disorders (4 papers), Parasitic infections in humans and animals (4 papers), Diagnosis and treatment of tuberculosis (4 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). The work is most often cited by research in Ophthalmology (101 citations), Infectious Diseases (166 citations), Immunology (183 citations), Epidemiology (163 citations) and Rheumatology (66 citations). A. Chabbou has collaborated with scholars based in Tunisia, France and Switzerland. Frequent co-authors include Mohamed‐Ridha Barbouche, Koussay Dellagi, Meriem Ben‐Ali, A. Hamzaoui, Kamel Hamzaoui, Fayçal Hentati, Kamel Hamzaoui, A Kahán, K. Ayed and L. Zakraoui. Their work appears in journals such as Journal of Medical Microbiology, Lara D. Veeken, Diagnostic and Interventional Imaging, Human Immunology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.